Bococizumab Withdrawn Phase 3 Trials for Primary Hyperlipidemia or Mixed Dyslipidemia Treatment
| Indications | Status | Purpose | Phase |
|---|---|---|---|
| Withdrawn | Treatment | 3 |
| clinicaltrials.gov Identifier | Title | Drugs |
|---|---|---|
| NCT02947334 | Efficacy And Safety Of Bococizumab For Lipid Lowering In Asian Hypercholesterolemia Subjects |